Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

Incyte

Status

Conditions: Aplastic Anemia

Treatments: Drug: Iticitinib

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT03906318

I-39110-18-05

Details and patient eligibility

About

Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria